APR 21, 2017 1:16 PM PDT

Malaria Parasite Inspires New Bladder Cancer Drug

WRITTEN BY: Xuan Pham

The malaria parasite was the inspiration behind the newest drug for the treatment of bladder cancer. In particular, the drug derived from the malaria protein may be potent against some intractable forms of the disease.

Image credit: Pixabay.com

Bladder cancer doesn’t get as much attention as other cancers, like breast, kidney, or prostate cancer. However, bladder cancer accounts for about 5% of all new cancer cases in the U.S., and it is the fourth most prevalent cancer in men. In 2016, the American Cancer Society estimates nearly 77,000 new bladder cancer cases, which may claim more than 16,000 lives.

Though some types of bladder cancer have good prognoses, some types are resistant to standard chemotherapy treatments, such as cisplatin. This increases the risks for metastasis, which severely diminishes the survival outcomes.

To find new drug targets for bladder cancer, the research team, led by Mads Daugaard of the University of British Columbia, turned to the malaria parasite. They found that a protein derived from the parasite, called VAR2CSA, can deliver chemotherapy agents directly to the tumors. This protein targets the drug to based a sugar molecule that’s only present in cancer cells and the placenta.

"This is the first study where we put the concept of using malaria proteins for cancer therapy into a direct clinical context," said Daugaard, the study’s senior investigator. "There is a massive clinical need to find new treatments for bladder cancer and we saw an opportunity to target this disease with our new malaria drug."

In a mouse model of drug-resistant bladder cancer, the team found that the malaria protein correctly targeted the cancer drugs to the tumors. In addition, the tumors shrank in response to the the malaria drug combo. Animals treated with the malaria protein were alive for longer than the untreated control animals.

"No second line treatment option is available," said Daugaard. "We're very excited by these results because it shows that we are on our way to developing a completely new treatment option for lethal bladder cancer. It has the potential to have a tremendous impact on patient care."

The team’s next plan is scaling up the production of the VAR2CSA drug combo for clinical trials.

Additional source: University of British Columbia via EurekAlert!

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 05, 2021
Cannabis Sciences
Can Smoking Cannabis Cause Lung Cancer?
APR 05, 2021
Can Smoking Cannabis Cause Lung Cancer?
So far, there is no firm consensus on whether smoking cannabis can cause lung cancer. As cannabis smoke contains many si ...
APR 19, 2021
Cancer
Understanding why pacreatic cancer metastasizes
APR 19, 2021
Understanding why pacreatic cancer metastasizes
New research published in the journal Gastroenterology reports on the mechanisms of metastatic pancreatic cancer cells, ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
MAY 21, 2021
Cancer
How to address low representation of Black Americans in cancer trials
MAY 21, 2021
How to address low representation of Black Americans in cancer trials
The Abramson Cancer Center at the University of Pennsylvania (ACC) has succeeded in more than doubling the enrollment of ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
Loading Comments...